GSE191184
ATAC sequencing data of 2102EP, VM-CUB-1, Caki-1 and DU-145 cells treated with epigenetic agent LAK31 (2102EP additionally: Romidepsin, Quisinostat and MZ-1) and DMSO as solvent control
ATAC sequencing data of cell lines of urological malignancies treated with epigenetic agents LAK31, Romidepsin, Quisinostat and MZ-1. Overall design: ATAC sequencing of cell lines (2102EP, VM-CUB-1, Caki-1, DU-145) treated with epigenetic agent LAK31 (2102EP additionally: Romidepsin, Quisinostat and MZ-1). DMSO was used as solvent control. Cells were treated with the epi-drug for 16 h.